Open Access<p>Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome</p>
Author(s) -
Siu Mee Cheng,
Vanessa Sarah Arciero,
Hanan Goldberg,
Camilla Tajzler,
Aileen Manganaro,
Natascha Kozlowski,
Leigha Rowbottom,
Rachel McDonald,
Ronald Chow,
Gaurav Vasisht,
Sharon Shaji,
Emily C L Wong,
Michele Petrovic,
Liying Zhang,
Catherine Phillips,
Paweł Zalewski,
Anil Kapoor,
Neil Fleshner,
Edward Chow,
Urban Emmenegger
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s213051
Subject(s) - medicine , prostate cancer , discontinuation , enzalutamide , radium 223 , proportional hazards model , cohort , hazard ratio , docetaxel , prostate specific antigen , abiraterone acetate , oncology , population , cancer , androgen deprivation therapy , bone metastasis , confidence interval , androgen receptor , environmental health